EP0975610A4 - Composes pharmaceutiques a base de tripeptides et de tetrapeptides - Google Patents

Composes pharmaceutiques a base de tripeptides et de tetrapeptides

Info

Publication number
EP0975610A4
EP0975610A4 EP98907625A EP98907625A EP0975610A4 EP 0975610 A4 EP0975610 A4 EP 0975610A4 EP 98907625 A EP98907625 A EP 98907625A EP 98907625 A EP98907625 A EP 98907625A EP 0975610 A4 EP0975610 A4 EP 0975610A4
Authority
EP
European Patent Office
Prior art keywords
tetrapeptides
tripeptides
pharmaceutical compounds
compounds based
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98907625A
Other languages
German (de)
English (en)
Other versions
EP0975610A1 (fr
Inventor
Bryan H Norman
Chuan Shih
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Hawaii at Manoa
Wayne State University
Eli Lilly and Co
University of Hawaii at Hilo
Original Assignee
University of Hawaii at Manoa
Wayne State University
Eli Lilly and Co
University of Hawaii at Hilo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Hawaii at Manoa, Wayne State University, Eli Lilly and Co, University of Hawaii at Hilo filed Critical University of Hawaii at Manoa
Publication of EP0975610A1 publication Critical patent/EP0975610A1/fr
Publication of EP0975610A4 publication Critical patent/EP0975610A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
EP98907625A 1997-02-26 1998-02-25 Composes pharmaceutiques a base de tripeptides et de tetrapeptides Withdrawn EP0975610A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3911597P 1997-02-26 1997-02-26
US39115P 1997-02-26
PCT/US1998/003666 WO1998038178A1 (fr) 1997-02-26 1998-02-25 Composes pharmaceutiques a base de tripeptides et de tetrapeptides

Publications (2)

Publication Number Publication Date
EP0975610A1 EP0975610A1 (fr) 2000-02-02
EP0975610A4 true EP0975610A4 (fr) 2000-05-17

Family

ID=21903772

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98907625A Withdrawn EP0975610A4 (fr) 1997-02-26 1998-02-25 Composes pharmaceutiques a base de tripeptides et de tetrapeptides

Country Status (5)

Country Link
EP (1) EP0975610A4 (fr)
JP (1) JP2001513775A (fr)
AU (1) AU6338698A (fr)
CA (1) CA2281107A1 (fr)
WO (1) WO1998038178A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5977387A (en) * 1996-08-30 1999-11-02 Eli Lilly And Company Process for preparing pharmaceutical compounds
AU775373B2 (en) 1999-10-01 2004-07-29 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996040184A1 (fr) * 1995-03-07 1996-12-19 University Of Hawaii Nouvelles cryptophycines obtenues par synthese
WO1997007798A1 (fr) * 1995-08-30 1997-03-06 Eli Lilly And Company Composes pharmaceutiques
WO1997023211A1 (fr) * 1995-12-22 1997-07-03 Eli Lilly And Company Composes pharmaceutiques
WO1998008506A1 (fr) * 1996-08-30 1998-03-05 Eli Lilly And Company Composes pharmaceutiques
WO1998008505A1 (fr) * 1996-08-30 1998-03-05 Eli Lilly And Company Composes pharmaceutiques

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194605A (en) * 1989-12-08 1993-03-16 Merck & Co., Inc. Cyclic renin inhibitors containing 2-substituted (3S,4S)-4-amino-5-cyclohexyl-3-hydroxy pentanoic acid, 2-substituted (3S,4S)-5-cyclohexyl-3,4-di-hydroxy pentanoic acid or 2-substituted (4S,5S)-5-amino-6-cyclohexyl-4-hydroxyhexanoic acid or its analogs
US5254682A (en) * 1989-12-08 1993-10-19 Merck & Co., Inc. Cyclic renin inhibitors containing 3(S)-amino-4-cyclohexyl-2(R)-hydroxy-butanoic acid or 4-cyclo-hexyl-(2R, 3S)-dihydroxybutanoic acid or related analogs
US5225528A (en) * 1990-02-27 1993-07-06 Merck & Co., Inc. Cyclic hexapeptide oxytocin antagonists

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996040184A1 (fr) * 1995-03-07 1996-12-19 University Of Hawaii Nouvelles cryptophycines obtenues par synthese
WO1997007798A1 (fr) * 1995-08-30 1997-03-06 Eli Lilly And Company Composes pharmaceutiques
WO1997023211A1 (fr) * 1995-12-22 1997-07-03 Eli Lilly And Company Composes pharmaceutiques
WO1998008506A1 (fr) * 1996-08-30 1998-03-05 Eli Lilly And Company Composes pharmaceutiques
WO1998008505A1 (fr) * 1996-08-30 1998-03-05 Eli Lilly And Company Composes pharmaceutiques

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KOISO, YUKIKO ET AL: "Effects of arenastatin A and its synthetic analogs on microtubule assembly", CHEM.-BIOL. INTERACT. (1996), 102(3), 183-191, 1996, XP000872569 *
See also references of WO9838178A1 *

Also Published As

Publication number Publication date
JP2001513775A (ja) 2001-09-04
CA2281107A1 (fr) 1998-09-03
WO1998038178A1 (fr) 1998-09-03
EP0975610A1 (fr) 2000-02-02
AU6338698A (en) 1998-09-18

Similar Documents

Publication Publication Date Title
NL300952I2 (nl) Peramivir en farmaceutisch aanvaardbare zouten daarvan
EE04440B1 (et) Kaparetseptori opioidpeptiidid ja farmatseutilinekompositsioon
BR9607317A (pt) Peptídios e composição farmacêutica
BR9607318A (pt) Peptidos e composição farmacêutica
DE69926351D1 (de) Ein statin und aspirin enthaltendes arzneimittel
NO20001776L (no) Medikamenter
PT881906E (pt) Composicao farmaceutica para a imunomodelacao baseada em peptideos e adjuvantes
ZA985618B (en) Sulfonamide compounds and pharmaceutical use thereof
DE69620930D1 (de) Platte und Stift
EE200000098A (et) Farmatseutiline kompositsioon piperidinoalkanooldekongestandi kombineerimiseks
DE69737936D1 (de) Arzneimittel
EP1010705A4 (fr) Derives tetrapeptides cycliques et leur utilisation medicinale
DE69616084D1 (de) Beuteltrenner-und spender
NO980546D0 (no) Farmasöytiske midler
BR9610396A (pt) Formulação farmacêutica
DK0991658T3 (da) Dolastatin 15-derivater
PT906301E (pt) Derivados de benzofurilo e a sua utilizacao
EP0850057A4 (fr) Composes pharmaceutiques
EE04001B1 (et) Peptiidne farmatseutiline kompositsioon
CZ2000522A3 (cs) Farmaceutický prostředek na bázi piperidinalkanolového antihistaminika a použití
FR2742053B1 (fr) Compositions pharmaceutiques a base de mequitazine
FR2772272B1 (fr) Compositions pharmaceutiques a base de dalfopristine et de quinupristine et leur preparation
EE9800275A (et) Misolastiini sisaldavad prolongeeritud toimega farmatseutilised preparaadid
FR2780011B3 (fr) Ensemble a plaque a insigne et contre-plaque
PT949923E (pt) Composicoes farmaceuticas estabilizadas a base de quinupristina e de dalfopristina e sua preparacao

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990819

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL PAYMENT 19990810;LT PAYMENT 19990819;LV PAYMENT 19990819;RO PAYMENT 19990819;SI PAYMENT 19990819

RIC1 Information provided on ipc code assigned before grant

Free format text: 7C 07D 273/00 A, 7C 07D 413/06 B, 7A 61K 31/395 B

A4 Supplementary search report drawn up and despatched

Effective date: 20000330

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20011115

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20020326